Patent Yard Sign in
Canadian application, no grantCanada

Gabusectin derivatives, method for the production thereof and use of the same

CA 2467251 A1 · Owner: Schiell, Matthias · Inventors: Toti, Luigi; Knauf, Martin; Markus-Erb, Astrid

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to compounds of formula (I) which are formed by the micro-organism ST 003236 (DSM 14476) during fermentation. The invention also relates to a method for producing said compounds and to the derivation thereof, to pharmaceuticals containing a compound of formula (I) and to the use of the same for producing a pharmaceutical.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed November 7, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended November 7, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by November 7, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledNovember 7, 2002
GrantedNo grant recorded
Term endedNovember 7, 2022
Patent numberCA 2467251 A1
Classification (IPC)C12N1/14 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedNov 7, 2002Term endedNov 7, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.